Abstract
The history of the pharmacology of antiepileptic drugs is now over 50 years old and much of the pioneering work can be traced to the discovery and development of phenytoin. The history and details of that particular research have recently been summarized and reviewed [7]. The use of pentylenetetrazol to produce chemoshock seizures and the subsequent discovery of trimethadione brought the science of pharmacology into the domain of antiepileptic drug testing in an even more permanent way. Toman, Swinyard, Goodman, Brown, Richards and Everett published a series of papers that further developed and quantified maximal electroshock and pentylenetetrazol models of epilepsy [31,30,29,28,5] that remain key components in the preclinical testing and evaluation of antiepileptic drugs (AEDs). Among this pioneering work one finds constant emphasis on not only refinement of methods useful for detection of antiepileptic drug efficacy, but on estimation of drug selectivity as a very important consideration.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Albertson, T.E., Peterson, S.L., and Stark, L.G. (1980): Anticonvulsant drugs and their antagonism of kindled amygdaloid seizures in rats. Neuropharmacology 19: 643–652.
Barr, G.A. and Lithgow, T. (1983): Effect of age on benzodiazepine induced behavioral convulsions in rats. Nature 302: 431–432.
Clark, C.R. (1987): Comparative anticonvulsant activity and neurotoxicity of 4-amino-N-(2,6-dimenthylphenyl)benzamide and prototype antiepileptic drugs in mice and rats. Epilepsia 29 (2): 198–203.
Clark, C.R., Sansom, R.T., Lin, C-M, and Norris, G.N. (1985): Anticonvulsant activity of some 4-aminobenzanilides. J. Med. Chem. 28: 1259–1262.
Everett, G.M. and Richards, R.K. (1944): Comparative anticonvulsant action of 3,5,5-trimethyloxazolidine-2,4-dione (tridione), ailantin and phenobarbital. J. Pharm. Exp. Ther. 81: 402–407.
Foster, A.C. and Kemp, J.A. (1989): Glycine maintains excitement. Nature 338: 377–378.
Freidlander, W.J. (1986): Putnam and Meritt and the discovery of dilantin. Epilepsia 27: (Suppl. 3).
Gilbert, M.E. and Cain, D.P. (1980): Electrode implantation in infant rats for kindling and chronic brain recording. Dev. Brain Res. 1: 553–555.
Gilbert, M.E. and Cain, D.P. (1982): A developmental study of kindling in the rat. Dev. Brain Res. 2: 321–328.
Harris, Q.L., Lewis, S.J., Young, N.A., Vajda, F.J. and Jarrott, B. (1988): Relationship between the dose-response effects of diazepam and clobazam on electroencephalographic parameters and on kindled amygdaloid seizure activity in rats. Clin. Exp. Pharmacol. Physiol. 15: 753–764.
Harrison, N.L., Majewska, M.D., Harrington, J.W. and Barker, J.L., (1987): Structure-activity relationships for steroid interaction with gamma-aminobutryic acidA receptor complex. J. Pharmacol. Exp. Ther. 241: 346–353.
Johnson, J.W. and Ascher, P. (1987): Glycine potentiates the NMDA response in cultured mouse brain neurons. Nature 325: 529–531.
Leander, J.D., Lawson, R.R., and Robertson, D.W. (1988): Anticonvulsant effects of a novel aminobenzamide (LY2011116) in mice. Neuropharmacology 27 (6): 623–628.
Nutt, D.J. and Little, H. (1986): Benzodiazepine-receptor mediated convulsions in infant rats: Effects of beta-carbolines. Pharmacol. Biochem. Behay. 24: 841–844.
Okazaki, M.M., McNamara, J.O. and Nadler, J.V. (1989): N-methyl-Daspartate receptor autoradiography in rat brain after angular bundle kindling. Brain Research 428: 359–364.
Parli, C.J., Potts, B.D., Kovach, P.M., Robertson, D.W. (1987): Metabolic fate of the anticonvulsant LY201116 in rats, mice, dogs, and monkeys. Pharmacologist 29: 176.
Peterson, D.W., Collins, J.F. and Bradford, H.F. (1983): The kindled amygdala model of epilepsy: Anticonvulsant action of amino acid antagonists. Brain Research 275: 169–172.
Peterson, S.L., (1986): Glycine potentiates the anticonvulsant action of diazepam an phenobarbital in kindled amygdaloid seizures of rats. Neuropharmacology 25 (12): 159–1363.
Peterson, S.L. (1989): Glycine potentiates diazepam and sodium divalproate in subcutaneous pentylenetetrazol seizures. Soc. Neurosci. Abstr., in press.
Peterson, S.L., Trzeciakowski, J.T., Boehnke, L.E. and Riegel, R.N. (1988): Glycine potentiates phenobarbital, carbamazepine and MK-801 in maximal electroshock seizures. Soc. Neurosci. Abstr. 14: 865.
Raines, A., Blake, G.J., Richardson, B., and Gilbert, M.B. (1979): Differential selectivity of several barbiturates on experimental seizures and neurotoxicity in the mouse. Epilepsia 20: 105–113.
Robertson, D.W., Lawson, R.R., Rathbun, R.C., and Leander, J.D. (1988): Pharmacology of LY201409, a potent benzamide anticonvulsant. Epilepsia 29 (6): 760–769.
Schulz, D.W. and MacDonald, R.L. (1981): Barbiturate enhancement of GABA-mediated inhibition and activation of chloride ion conductance: Correlation with anticonvulsant and anesthetic actions. Brain Res. 209: 177–188.
Schwark, W.S. and Loscher, W. (1985): Comparison of the anticonvulsant effects of two novel GABA uptake inhibitors and diazepam in amygdaloid kindled rats. Naunyn-Schmiedeberg’s Arch. Pharmacol. 329: 367–371.
Seiler, N. and Sarhan, S. (1984): Synergistic anticonvulsant effects of a GABA agonist and glycine. Gen. Pharmac. 15: 367–369.
Stark, L.G., Albertson, T.E., Joy, R.M., He, P. and Streisand, J. (1986): The acquisition of a kindled response in developing rats using 24-h intertrial intervals. Dev. Brain Res. 24: 291–294.
Swinyard, E.A. and Woodhead, J.H. (1982): Experimental detection, quantification, and evaluation of anticonvulsants. In: Antiepileptic Drugs, ( Woodbury, D.N., Ed.), pp. 111–126. Raven Press, New York.
Swinyard, E.A., Brown, W.C., and Goodman, L.S. (1952): Comparative assays of antiepileptic drugs in mice and rats. J. Pharmacol. Exp. Ther. 106: 319–330.
Toman, J.E.P. (1964): Animal techniques for evaluating anticonvulsants. In: Animal and Clinical Pharmacologic Techniques in Drug Evaluation, (Nodine, J.H. and Siegler, P.E., Eds.), Chapter 46, pp. 348–352, Year Book Medical Publishers, Chicago.
Toman, J.E.P., Goodman, L.S. (1948): Anticonvulsants. Physiological Reviews 28 (1): 409–432.
Toman, J.E.P., Swinyard, E.A., and Goodman, L.S. (1946): Properties of maximal seizures and their alteration by anticonvulsant drugs and other agents. J. Neurophysiol. 9: 231–239.
Toth, E. and Lajtha, A. (1984): Glycine potentiates the action of some anticonvulsant drugs in some seizure models. Neurochem. Res., 12: 1711–1718.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Plenum Press, New York
About this chapter
Cite this chapter
Stark, L.G., Peterson, S.L., Albertson, T.E. (1990). Pharmacological and Toxicological Evaluation of Potential Antiepileptic Drugs in the Kindling Model of Epilepsy. In: Wada, J.A. (eds) Kindling 4. Advances in Behavioral Biology, vol 37. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5796-4_20
Download citation
DOI: https://doi.org/10.1007/978-1-4684-5796-4_20
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-5798-8
Online ISBN: 978-1-4684-5796-4
eBook Packages: Springer Book Archive